Clincosm LogoSign in Get a demo

relapsed or refractory hematologic malignancies

Showing 1 - 2 of 2
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

Recruiting
  • Relapsed or Refractory Hematologic Malignancies
  • Chicago, Illinois
    University of Illinois Cancer Center
Sep 27, 2022

Relapsed or Refractory Hematologic Malignancies Trial in United States (Trichostatin A)

Unknown status
  • Relapsed or Refractory Hematologic Malignancies
  • Trichostatin A
  • Washington, District of Columbia
  • +4 more
Feb 11, 2019